Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research.
about
MDMA and the “Ecstasy Paradigm”The pharmacology and toxicology of "ecstasy" (MDMA) and related drugsVerbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical PerspectiveMechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats."Partying" hard: party style, motives for and effects of MDMA use at rave parties.Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014).Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research.Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care.Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.The effects of stereotype threat on cognitive function in ecstasy users.Perceived risk associated with ecstasy use: a latent class analysis approach.Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach.Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history.Preventing problems in Ecstasy users: reduce use to reduce harm.Acute psychological and neurophysiological effects of MDMA in humans.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers.Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changesReward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.Review: The neuropathology of drug abuse.Association of study characteristics with estimates of effect size in studies of ecstasy use.Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs).Psychiatric disorders and their correlates among young adult MDMA users in Ohio.Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.Application of the Passionate Attachment Model to Recreational Use of MDMA/Ecstasy.Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.Differences between Ecstasy-using and nonusing methamphetamine users.Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
P2860
Q21558618-2EE7F6FB-2192-489C-9913-4A353B76655FQ28361466-7C43878E-B0C1-4F18-AF24-5D1DC5CAD31DQ28486090-93977476-E5FE-4124-A72D-711C50CE3C03Q28550342-C8AE783A-04BA-4E9A-A64B-AB97335CC51BQ30387357-83F56280-338C-4FF1-86C5-D9B4E94CF813Q30541451-062425DD-B85F-4B14-B1BD-BF25663ADC10Q31033312-A1ABB422-E64C-447C-95EE-4DBFF5BABCD5Q34025177-FDE388AF-95FD-4B6D-B910-D33302F048E5Q34407992-DCD59F22-34FC-46D8-9687-99FDBF145BD3Q34528465-839C164C-88A2-4600-877C-2F00EADF6D76Q34542261-8F4ECDD9-DF00-4308-A08F-D056DCD8B385Q34545356-B2F80EC8-DC69-47CF-8FE5-688069B2F035Q34560975-704DB074-7504-4FE4-AD5E-1C7C3DB036EDQ34629707-AD65BAF4-565F-4CB0-8FDB-4A2C12B88C6CQ34656611-7DD48C16-FC6F-47F1-A05F-00E6AEB5F837Q34982523-FAED1E83-2303-4519-A580-BD593812E6CCQ34982526-373126E4-FD4C-4F3A-BE33-4D75A50DB4BFQ35105557-E037D7F6-76CE-4C75-BA34-D4CF3B2BC11BQ35105559-E9E052AB-B933-4B0B-B43D-7D9789D8FB40Q36020276-1EC3EE9D-2530-4304-A740-B181AE4F4F63Q36410784-DD982B4F-8E02-477B-B294-C7DE1CE12FAFQ36410788-77B15451-6D96-426A-9480-614C0D5ED677Q36617655-0FCBB8EC-F03E-4FA7-86E5-DEB0C285EA52Q36803318-D9B6180A-2A11-461B-9301-F2EEC72CFC3EQ37800120-64CBE95E-B401-4D67-9998-7CE78394AE5FQ37936690-FBE93999-DEE0-4D2F-A947-8A12F7032103Q38419302-0ABBDF79-66C9-44DE-B4F0-B6F6F98B14E2Q39221467-9EEC5944-8CDD-4A0F-9F2D-53A4A935E90BQ39754329-B521212B-D070-4A31-A8C0-86B9697E52F0Q40346595-46FD5EDB-12E8-44E1-B46B-E8C3C34C826EQ41350161-C062C0AE-3CAB-412C-9E6F-30AB6935F649Q43096892-F339659B-9DD5-4B45-A125-2C164B2FD233Q44252300-013BF5DA-DE13-4299-9D76-2248437FAAF0Q44255973-4F7D17A9-47D8-4B66-9462-449B60A74CD3Q44400666-59DAF91D-A452-4C07-882B-8915E2F4EB00Q44445337-0DD10571-2BD0-4294-A69F-2D2815516E8BQ44768744-C6106583-575D-4FCA-A6D1-3EF19422467BQ46334066-EE41FC48-6BAA-48D4-B5BA-5EF7F6E298C3Q46477520-19479D46-0864-4425-B7B9-58E776DA06EAQ46813783-189E41F7-78ED-4A69-AA84-21158C76CB11
P2860
Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@ast
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@en
type
label
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@ast
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@en
prefLabel
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@ast
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@en
P356
P1433
P1476
Is MDMA ('Ecstasy') neurotoxic ...... ological problems in research.
@en
P2093
P356
10.1159/000026668
P577
2000-01-01T00:00:00Z